Pek Yee Lum
Directeur Général chez Auransa, Inc.
Profil
Pek Yee Lum is the founder of Auransa, Inc. Prior to founding Auransa, Lum worked as a Scientific Director at Rosetta Inpharmatics LLC.
She also held positions as Senior Director at iPierian, Inc. and Vice President-Products & Solutions at SymphonyAI Sensa LLC.
Lum earned a doctorate degree from the University of Washington and a graduate degree from Hokkaido University.
Postes actifs de Pek Yee Lum
| Sociétés | Poste | Début |
|---|---|---|
Auransa, Inc.
 Auransa, Inc. BiotechnologyHealth Technology Auransa, Inc. develops biotechnologies and monoclonal antibody medicines. It applies novel data analysis techniques and algorithms to every step of the drug discovery and development pipeline to identify compounds, markers and new targets for specific patient populations. The firm offers SMarTR engine, a proprietary automated and scalable computational platform that characterizes disease heterogeneity and identifies compounds for specific patient sub-populations. The company was founded by Pek Yee Lum and Viwat Visuthikraisee and is headquartered in Palo Alto, CA. | Directeur Général | - |
Anciens postes connus de Pek Yee Lum
| Sociétés | Poste | Fin |
|---|---|---|
iPierian, Inc.
 iPierian, Inc. Pharmaceuticals: MajorHealth Technology ierian, Inc. developed and manufactured biopharmaceutical products. The firm's lead antibody, IPN007, represents a new approach to treating neurodegenerative disease by targeting a novel form of secreted Tau protein. The company was founded in 2007 and is headquartered in South San Francisco, CA. | Directeur/Membre du Conseil | 01/08/2010 |
Rosetta Inpharmatics LLC
 Rosetta Inpharmatics LLC BiotechnologyHealth Technology Rosetta Inpharmatics LLC designed and implemented DNA microarray gene expression systems. The company provided software for use in informational genomics. The company was founded in may 29, 2009 and was headquartered in Seattle, WA. | Directeur Technique/Scientifique/R&D | - |
SymphonyAI Sensa LLC
 SymphonyAI Sensa LLC Packaged SoftwareTechnology Services SymphonyAI Sensa LLC develops interactive analysis and visualization software. Its technology is used to discover new drug therapies, uncover the causes of diseases, root out financial fraud, accelerate energy exploration, discover customer segmentation and complement other Big Data solutions. The company was founded by Gurjeet Singh, Gunnar Carlson and Harlan Sexton in 2008 and is headquartered in Menlo Park, CA. | Corporate Officer/Principal | - |
Formation de Pek Yee Lum
| University of Washington | Doctorate Degree |
| Hokkaido University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Rosetta Inpharmatics LLC
Rosetta Inpharmatics LLC BiotechnologyHealth Technology Rosetta Inpharmatics LLC designed and implemented DNA microarray gene expression systems. The company provided software for use in informational genomics. The company was founded in may 29, 2009 and was headquartered in Seattle, WA. | Health Technology |
SymphonyAI Sensa LLC
SymphonyAI Sensa LLC Packaged SoftwareTechnology Services SymphonyAI Sensa LLC develops interactive analysis and visualization software. Its technology is used to discover new drug therapies, uncover the causes of diseases, root out financial fraud, accelerate energy exploration, discover customer segmentation and complement other Big Data solutions. The company was founded by Gurjeet Singh, Gunnar Carlson and Harlan Sexton in 2008 and is headquartered in Menlo Park, CA. | Technology Services |
iPierian, Inc.
iPierian, Inc. Pharmaceuticals: MajorHealth Technology ierian, Inc. developed and manufactured biopharmaceutical products. The firm's lead antibody, IPN007, represents a new approach to treating neurodegenerative disease by targeting a novel form of secreted Tau protein. The company was founded in 2007 and is headquartered in South San Francisco, CA. | Health Technology |
Auransa, Inc.
Auransa, Inc. BiotechnologyHealth Technology Auransa, Inc. develops biotechnologies and monoclonal antibody medicines. It applies novel data analysis techniques and algorithms to every step of the drug discovery and development pipeline to identify compounds, markers and new targets for specific patient populations. The firm offers SMarTR engine, a proprietary automated and scalable computational platform that characterizes disease heterogeneity and identifies compounds for specific patient sub-populations. The company was founded by Pek Yee Lum and Viwat Visuthikraisee and is headquartered in Palo Alto, CA. | Health Technology |